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SUMMARY 
 
 
Background: Although coronary heart disease (CHD) mainly occurs in patients over 
the age of 50, younger patients can be affected as well. Most studies have used an age 
cut-off of 45 years to define "young" patients with CHD or acute coronary syndrome 
(ACS). We used this definition to investigate clinical characteristics and outcomes of 
ACS young patients in a large international cohort. 
Methods: Between October 2010 and April 2016, 14, 931 ACS patients were enrolled 
in the ISACS-TC registry (ClinicalTrials.gov NCT01218776). Of these patients, 
1,182 (8%) were aged ≤ 45 years old (mean age 40.3 years, 15.8% female). The 
primary end-point was ST segment elevation myocardial infarction (STEMI) as index 
event and 30-day all-cause mortality. Percent diameter stenosis of 50% or less was 
defined as insignificant coronary disease. 
Results: STEMI is the most common clinical manifestation of ACS in the younger 
cases (68% versus 59.6%). Younger patients had a higher incidence of insignificant 
coronary artery disease (7.6% versus 5.4%) and single vessel disease (66.9% versus 
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52.5%). Conversely, three-vessel disease was less common (7.7% versus 16.3%) in 
the younger patients . Smoking was the most important risk factor in this population 
(61.2% versus 33.7%). Predictors of ACS in the young population included male sex 
(OR: 2.21; 95% CI 1.86-2.62), smoking habit (OR: 1.10; 95% CI 1.06-1.16), and 
higher Body Mass Index (OR: 1.04; 95% CI 1.01-1.06). Thirty-day unadjusted 
survival rates were 98.7% versus 93.1% for young and older patients respectively. 
After adjusting for baseline characteristics, medications at admission and reperfusion 
therapy, age ≤ 45 years old was a predictor of survival in men (OR 0.25, 95% CI 0.10-
0.64) , but not in women (OR 1.51, 95% CI 0.55-4.18). Moreover, younger women 
had worse outcomes than men of a similar age (OR 6.84, 95% CI 2.23-20.97). 
Conclusion: ACS at a young age is characterized by less severe coronary disease and 
worse clinical presentation. Women have higher mortality than men. Factors 
underlying ACS in young patients and higher mortality rates in female sex warrant 
further investigation 
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CHAPTER 1 
 
INTRODUCTION 
 
 
1.1 BACKGROUND 
Although coronary heart disease (CHD) mainly occurs in patients over the age of 45, 
younger patients can be affected as well. Nowadays our knowledge about acute 
coronary syndrome (ACS) derives from studies in older cohort of patients. Most 
studies on patients with chest pain have excluded individuals under 40 years of age 
[1-3]. Comparatively few studies have focused on the clinical presentation, treatment 
and outcome of ACS in young patients [4-9].  
Coronary artery disease in young age represents an issue of increasing clinical interest 
considering the years of potential life lost, long-term disability [1,6,10-12], significant 
morbidity, psychological effects, and financial constraints for the family of those 
people [13]. The actual incidence of the ACS in young depends upon the cut-off age 
used in the investigations. It was found to range from 0.4% to19% [14-18]. The 
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prevalence of the disease was found to be greater in men than women. Women 
represents approximately from 5% to 25% of all myocardial infarction in young 
patients [9,14,19-23]. 
 
The causes for ACS among patients aged less than 45 are still largely unknown. 
Among young patients with reported atherosclerosis, cigarette smoking was found to 
be common in up to 92%. As well, obesity and lack of physical activity were found to 
be more common in patients who had their ACS aged less than 45 years [13,14,24]. 
Much more importantly, it is unknown whether having an ACS at a younger age 
carries a worse prognosis, or requires a different management from that commonly 
used in the older patients. [5] [25-32]. 
 
 
1.2 AIM OF THE STUDY 
The purpose of this study was to investigate the clinical presentation and outcome of 
patients aged 45 years or younger hospitalized for ACS in a large international cohort. 
In order to analyse specific differences, findings of young patients were compared 
with those of the older population (aged 45 years or more) 
 
1.3 WHY 45 YEARS OR YOUNGER? 
The comparison among studies about young ACS patients is difficult because of the 
lack of uniformity concerning the definition for "youth”. In addition there are a 
limited number of articles published on the topic. The range between 35 to 55 years 
was used by several studies to identify a population of ACS patients relatively young 
as compared with the old cohorts that usually are affected by it. The majority of these 
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studies used the age cut-off at 45 years [9, 17, 23]. The same age will be used in the 
current study. The main reason supporting this choice is excluding the influence of 
hormonal disorders on the course of coronary artery disease during menopause in 
women [22]. Early menopause is associated with an increased risk for CHD[33], [34].  
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CHAPTER 2 
 
MATERIAL AND METHODS 
 
 
2.1 SETTING AND DESIGN 
The International Survey of Acute Coronary Syndromes in Transitional Countries 
(ISACS-TC [ClinicalTrials.gov NCT01218776]) is a large observational and 
multinational registry [35-39]. ISACS-TC is both a retrospective and prospective 
study, aiming to collect data of patients with ACS, and herewith control and optimize 
internationally guideline recommended therapies in countries with economy in 
transition. Data were collected from 41 centres in 12 countries in Europe(including 
Bosnia and Herzegovina, Croatia, Italy, Kosovo, Lithuania, Macedonia, Hungary, 
Moldova, Montenegro, Romania, Russian Federation, Serbia). Among these, there 
were 22 tertiary healthcare services providing advanced medical investigation and 
treatment including PCI and/or cardiac surgery, and 19 secondary healthcare services 
providing intensive care in critical coronary care units.  
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Patients enrolled in the ISACS-TC were eligible for inclusion if they met the 
following criteria: age ≥ 18 years, symptoms consistent with acute cardiac ischemia, 
documented evidence of new or presumed new significant ST-segment-T wave (ST–
T) changes or new left bundle branch block on serial electrocardiograms and/or 
elevated biomarkers of myocardial necrosis according to universal standardized 
criteria [40]. Approximately 200 baseline variables were collected for each patient. 
The data coordinating centre has been established at the University of Bologna. The 
study was approved by the local research ethics committee from each hospital. 
 
2.2 STUDY POPULATION  
The study population consisted of 14,931 eligible patients with ACS enrolled between 
October 2010 and April 2016. Appropriateness of inclusion was adjudicated by a 
specialist cardiology considering clinical history, physical exam, ECG, cardiac 
biomarkers, angiography, and/or postmortem findings [40]. Patients included in the 
analysis were categorized into two groups: younger patients, aged ≤ 45 years old, and 
older patients, aged > 45 years old. They were followed-up for30 days.  
 
2.3 ENDPOINTS AND MEASUREMENTS 
The primary end-point was ST segment elevation myocardial infarction (STEMI) as 
index event and 30-day all-cause mortality. We also evaluated length of hospital stay, 
and the extent and severity of angiographic-defined coronary artery disease.  
Baseline risk was estimated using the Thrombolysis In Myocardial Infarction (TIMI) 
risk index score, which was calculated for each patient using the equation: (heart rate 
x [age/10]2/systolic blood pressure) [41]. Patients were categorized as belonging to 
one of the five incremental risk index ranges: <12.5, 12.5 to 17.5; 17.5 to 22.5; 22.5 to 
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30; and >30. Patients were subsequently, grouped in two simplified risk categories: 
low risk (range: <12.5) and medium-high risk (range: >12.5 to >30).  
Percent diameter stenoses of 50% or less were defined as insignificant coronary 
disease. 
 
2.1 STATISTICAL ANALYSIS 
We compared the baseline characteristics, management, angiographic findings and 
clinical outcomes of younger patients, aged ≤ 45 years old, and older patients, aged > 
45 years old. Baseline characteristics were reported as numbers and percentages for 
categorical variables and means (± standard deviation [SD]) for continuous variables. 
Comparisons between groups were made either by chi-square test for baseline 
categorical variables and a 2-sample t test for continuous variables. Estimates of the 
odd ratios (OR) and associated 95% confidence intervals (CI) were obtained with the 
use of multivariable logistic regression analysis to evaluate factors associated with 
ACS in the young population and with 30-day mortality. 
Constant covariates included in the analyses were: sex; cardiovascular risk factors: 
(history of hypercholesterolemia, hypertension and diabetes, smoking status, family 
history of CAD, Body Mass Index [BMI]); clinical history of ischemic heart disease 
(prior angina pectoris, prior myocardial infarction, prior percutaneous coronary 
intervention [PCI], and prior coronary artery bypass graft [CABG] surgery), clinical 
history of cardiovascular disorders (prior peripheral artery disease, prior heart failure 
and prior stroke), severity of clinical presentation (STEMI at index event, systolic 
blood pressure, heart rate, TIMI risk index and chronic kidney disease) and time from 
symptoms onset to admission ≤ 12 hours. 
B. Ricci Thesis 
 
 
 
10 
 
Covariates introduced in the secondary analyses, as dummy variables, were: in-
hospital acute medication, namely aspirin, clopidogrel, heparins, beta-blockers and 
ACE-Inhibitors and reperfusion therapy, including PCI and fibrinolysis.  
Moreover, we performed secondary analyses to get insights on potential sex 
differences in the younger populations. 
We had complete data on age, gender and 30-day mortality. Some patients had 
missing data on other variables. We imputed the missing values of the clinical 
variables whose missing rate was less than 10% using STATA software. For the 
clinical features, whose missing rate exceeded 10%, we carried out a Pearson Chi-
square statistical test for independence between those features and mortality. Only the 
variable “hypercholesterolemia" had missing rates that exceeds 10%, and it was found 
to be statistically dependent on the endpoint mortality. We therefore did not dismiss 
this variable from the predictive model of mortality and we kept it as missing [42].  
For all analysis, statistical significance was defined as a value of p <0.05 and STATA 
11 (StataCorp; College Station, Texas) was used. 
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CHAPTER 3 
 
RESULTS 
 
 
There were 14,931 patients with a diagnosis of ACS enrolled in the ISACS-TC 
registry between October 2010 and April 2016. The mean age of our cohort was 62.6 
± 11.9 years and 4,717 (31.6%) subjects were women. Of these patients, 1,182 (7.9%) 
were aged ≤ 45 years.  
 
3.1 PATIENT CHARACTERISTICS 
Clinical variables at baseline for the younger (aged ≤ 45 years old) and older groups 
(aged 46 years and older), are shown in Table 1. The proportion of women was 
significantly lower in the younger group. The analysis of the conventional 
cardiovascular risk factor profiles showed that current smoking was the most 
prevalent risk factor in young patients, with more than 60% of young patients being 
current smokers. This prevalence was significantly higher (P<0.001) than in the older 
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age group. Almost 40% of young patients had a family history of CAD, significantly 
more than in older patients. Young patients also had higher mean of BMI than the 
older one. On the other hand, diabetes, hypercholesterolemia and hypertension were 
less frequent in younger patients. As expected, younger patients had lower rates of 
history of ischemic heart disease and other comorbidities.  
 
3.2 CLINICAL PRESENTATION AND MANAGEMENT  
The distribution of STEMI and non ST-segment elevation ACS (NSTE-ACS) was 
significantly different between young and older patients: STEMI was the most 
common clinical manifestation of ACS in the younger cases (Table 1). Less than 12% 
of younger patients had a medium-high TIMI Risk Index, whereas this proportion 
significantly increased in older group. Moreover, a higher proportion of younger 
patients reached the hospital before 12 hours from symptoms onset.  
The rate of administration of in-hospital medications, namely aspirin and clopidogrel, 
was higher in younger patients, but younger patients received less frequently 
angiotensin-converting-enzyme (ACE) inhibitors. A higher proportion of younger 
patients received percutaneus reperfusion therapy, both STEMI and NSTE-ACS 
(Table 1). 
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Table 1. Baseline characteristics of the study population 
Variables 
Younger 
patients 
≤ 45 yrs. 
N=1,182 
 
Older patients 
> 45 yrs. 
N=13,749 
 P value 
Age - yrs 40.3 ± 4.5  64.6 ± 10.3  <0.001 
Women 187 (15.8)  4,530 (32.9)  <0.001 
Cardiovascular risk factors - n (%)     
Hypercholesterolemia - n/total (%) 409/1,060(38.6)  5,008/11,839(42.3)  0.019 
Diabetes 117 (9.9)  3,624 (26.4)  <0.001 
Hypertension 523 (44.2)  9,616 (69.9)  <0.001 
Current smoker 723 (61.2)  4,636 (33.7)  <0.001 
Body Mass Index – kg/m2 27.4 ± 4.5  27.1 ± 2.9  0.0004 
Family history of CAD 469 (39.7)  4,096 (29.8)  <0.001 
Clinical history of ischemic heart disease - n (%)     
Prior angina pectoris  122 (10.3)  3,118 (22.7)  <0.001 
Prior myocardial infarction  126 (10.7)  2,440 (17.7)  <0.001 
Prior PCI 129 (10.9)  1,702 (12.4)  0.14 
Prior CABG 9 (0.8)  373 (2.7)  <0.001 
Comorbidities - no. (%)     
Prior heart failure 26 (2.2)  817 (5.9)  <0.001 
Prior stroke 7 (0.6)  635 (4.6)  <0.001 
Prior peripheral artery disease 12 (1.0)  339 (2.5)  0.002 
Chronic kidney disease 20 (1.7)  921 (6.7)  <0.001 
Clinical presentation - n (%)     
STEMI 804 (68.0)  8,193 (59.6)  <0.001 
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NSTEMI 305 (25.8)  4,167 (30.3)  <0.001 
Unstable angina 73 (6.2)  1,389 (10.1)  <0.001 
Systolic blood pressure at baseline - 
mmHg  
139.6 ± 22.1  140.9 ± 24.1  0.09 
Heart rate at baseline at baseline - beats 
per minute 
81.0 ± 23.1  81.3 ± 21.6  0.65 
TIMI Risk Index  9.8 ± 5.1  25.6 ± 13.5  <0.001 
Medium-High TIMI Risk Index  143 (12.1)  12,896 (93.9)  <0.001 
Time from symptoms onset to 
admission ≤ 12 hours 
769 (79.4)  8,326 (71.9)  0.001 
Hospital stay - days 6.0 ± 4.3  6.9 ± 6.2  <0.001 
In - hospital acute medications - n (%)     
Aspirin 1,157 (98.4)  13,199 (96.8)  0.003 
Clopidogrel 1,092 (92.9)  12,071 (88.9)  <0.001 
Heparins 840 (83.7)  9,112 (81.6)  0.087 
β blockers 321 (27.4)  4,075 (30.0)  0.06 
ACE inhibitors 301 (25.6)  4,294 (31.6)  <0.001 
Reperfusion therapy - n (%)     
STEMI patients       
Primary PCI  575 (71.5)  5,252 (64.1)  <0.001 
Fibrinolysis  119 (14.8)  957 (11.7)  0.009 
CABG 2 (0.2)  67 (0.8)  0.07 
NSTE-ACS patients      
PCI  233 (62.5)  2,411 (43.9)  <0.001 
CABG 12 (3.2)  292 (5.3)  0.07 
Outcomes - n (%)      
30-day all-cause mortality 16 (1.3)  950 (6.9)  <0.001 
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Data are n (%), mean (± Standard Deviation), unless stated otherwise. 
CAD= coronary artery disease; PCI=percutaneous coronary intervention; CABG=coronary artery 
bypass graft; STEMI=ST-segment elevation myocardial infarction; NSTEMI= Non ST-segment 
elevation myocardial infarction; TIMI= Thrombolysis In Myocardial Infarction; ACE=angiotensin-
converting-enzyme. 
 
 
3.3 ANGIOGRAPHYC DATA 
The extension and severity of angiographic-defined coronary artery disease are shown 
in Figure 1. Young patients showed less diffuse atherosclerotic lesions as compared 
to patients of the older age group. Younger patients had a higher incidence of 
insignificant coronary artery disease (7.6% versus 5.4%) and single vessel disease 
(66.9% versus 52.5%). Conversely, three-vessel disease was less common (7.7% 
versus 16.3%) in the younger patients.  
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Figure 1.Extent, and severity of angiographic-defined coronary artery disease 
of population. 
 
LM= left main; LAD= left anterior descending artery; CX= Circumflex artery; RCA, right 
coronary artery. 
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3.4 FACTORS ASSOCIATED WITH ACS IN YOUNG 
POPULATION 
Predictors of ACS in the young population included male sex, smoking habit, family 
and higher BMI (Table 2)  
 
Table 2. Multivariate analysis of factors associated with ACS in the young population 
 OR  95%CI  P value 
Male 2.21  1.86-2.62  <0.001 
Diabetes 0.91  0.85-0.98  0.013 
Hypercholesterolemia 1.08  0.94-1.24  0.26 
Current smoker 1.10  1.06-1.16  <0.001 
Hypertension 0.59  0.52-0.68  <0.001 
Family history of CAD 0.99  0.96-1.02  0.36 
Body Mass Index  1.04  1.01-1.06  <0.001 
Prior angina pectoris  0.47  0.38-0.58  <0.001 
Prior myocardial infarction  0.65  0.52-0.80  <0.001 
Prior PCI/CABG 1.10  0.89-1.35  0.36 
Prior heart failure 0.59  0.39-0.90  0.014 
Prior stroke 0.13  0.05-0.32  <0.001 
Prior peripheral artery disease 0.63  0.34-1.17  0.14 
Chronic kidney disease 0.72  0.54-0.95  0.022 
CAD= coronary artery disease; PCI=percutaneous coronary intervention; CABG=coronary artery 
bypass graft. 
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3.5 FACTORS ASSOCIATED WITH 30-DAY ALL-CAUSE 
MORTALITY: THE ROLE OF AGE 
When all of the baseline variables (constant covariates) were assessed simultaneously 
in multivariable analysis (Table 3), there were 8 factors associated with 30-day all-
cause mortality: women, history of diabetes, medium-high TIMI Risk Index , STEMI 
as index event, chronic kidney disease, clinical presentation with higher heart rate or 
lower systolic blood pressure, and clinical history of cardiovascular disorders. Age of 
45 years or less had a significant protective effect on mortality (OR: 0.48; 95% CI 
0.25-0.92). Linear regression analysis was repeated separately in men and women 
(Table 3). Interestingly, young age remained a factor associated with survival in men 
(OR 0.25, 95% CI 0.10-0.64), but not in women (OR 1.51, 95% CI 0.55-4.18). 
Moreover, current smoker and STEMI as index event were factors associated with 30-
day mortality in women, but not in men. A shorter delay from symptoms onset to 
hospital admission had a protective effect only for women and not for men. Whereas a 
higher BMI had a positive effect for the prognosis of men, but not of women. The 
adjusted OR for mortality associated with younger age did not change when 
controlling for medications used at admission (Table 4) and reperfusion therapy.  
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Table 3.  Multivariate analysis of factors associated with 30-day all-cause mortality in overall population and according to sex 
Variables 
 Overall population  Women  Men 
OR (95%CI) P value  OR (95%CI) P value  OR (95%CI) P value 
Female   1.57 (1.32-1.84) <0.001  - -  - - 
Age ≤ 45 yrs.  0.48 (0.25-0.92) 0.028  1.51 (0.55-4.18) 0.42  0.25 (0.10-0.64) 0.004 
Diabetes  1.05 (1.002-1.12) 0.042  1.06 (0.97-1.17) 0.20  1.06 (0.99-1.13) 0.11 
Hypercholesterolemia   0.40 (0.33-0.49) <0.001  0.39 (0.29-0.52) <0.001  0.41 (0.32-0.53) <0.001 
Current smoker  1.03 (0.97-1.08) 0.32  1.08 (1.01-1.16) 0.032  0.97 (0.89-1.06) 0.55 
Hypertension  1.08 (0.99-1.17) 0.064  1.05 (0.92-1.19) 0.48  1.09 (0.98-1.21) 0.087 
Family history of CAD  1.01 (0.98-1.04) 0.58  1.001 (0.95-1.05) 0.94  1.01 (0.97-1.05) 0.56 
Body Mass Index   0.96 (0.94-0.99) 0.011  0.99 (0.96-1.03) 0.72  0.93 (0.90-0.98) 0.002 
Medium-High TIMI Risk Index   2.07 (1.51-4.83) 0.001  4.14 (1.41-12.17) 0.010  2.21 (1.10-4.41) 0.025 
STEMI  1.39 (1.15-1.68) 0.001  1.63 (1.21-2.20) 0.001  1.21 (0.97-1.59) 0.086 
Systolic blood pressure at baseline  0.98 (0.97-0.98) <0.001  0.97 (0.97-0.98) <0.001  0.97 (0.97-0.98) <0.001 
Heart rate at baseline at baseline  1.01(1.002-1.007) <0.001  1.004 (1.001-1.01) 0.014  1.005 (1.001-1.01) 0.006 
Time from symptoms onset to admission ≤ 12 
hours 
 0.75 (0.63-0.88) 0.001  0.64 (0.49-0.85) 0.001  0.83 (0.66-1.05) 0.14 
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Chronic kidney disease  1.32 (1.23-1.42) <0.001  1.25 (1.11-1.41) <0.001  1.36 (1.24-1.50) <0.001 
Clinical history of ischemic heart disease   1.11 (0.94-1.32) 0.22  0.96 (0.73-1.25) 0.75  1.22 (0.97-1.53) 0.085 
Clinical history of cardiovascular disorders  2.02 (1.65-2.48) <0.001  1.66 (1.19-2.31) 0.003  2.26 (1.74-2.94) <0.001 
CAD= coronary artery disease; TIMI= Thrombolysis In Myocardial Infarction; STEMI=ST-segment elevation myocardial infarction; PCI=percutaneous coronary 
intervention; CABG=coronary artery bypass graft. 
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Table 4. Multivariate models to assess the impact of various in-hospital acute medications and procedure on the odds of mortality for young patients: the 
role of young age 
  Overall population  Women  Men 
OR (95%CI) P value  OR (95%CI) P value  OR (95%CI) P value 
Model 1: Demographic and clinical factors          
30-day mortality  0.48 (0.25-0.92) 0.028  1.51 (0.55-4.18) 0.42  0.25 (0.10-0.64) 0.004 
Model 2: Model 1 including aspirin          
30-day mortality  0.48 (0.25-0.92) 0.027  1.63 (0.58-4.57) 0.35  0.24 (0.09-0.62) 0.003 
Model 3: Model 1 including aspirin and/or clopidogrel        
30-day mortality  0.48 (0.25-0.92) 0.027  1.53 (0.54-4.32) 0.42  0.25 (0.10-0.64) 0.004 
Model 4: Model 1 including heparins        
30-day mortality  0.48 (0.24-0.98) 0.046  1.68 (0.57-4.96) 0.34  0.21 (0.07-0.64) 0.006 
Model 5: Model 1 including β blockers          
30-day mortality  0.50 (0.26-0.98) 0.043  2.03 (0.68-6.06) 0.20  0.24 (0.09-0.62) 0.003 
Model 6: Model 1 including ACE inhibitors        
30-day mortality  0.46 (0.24-0.89) 0.021  1.53 (0.53-4.38) 0.43  0.23 (0.09-0.59) 0.002 
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Model 7: Model 1 including reperfusion therapy        
30-day mortality  0.51 (0.26-0.98) 0.043  1.61 (0.57-4.55) 0.37  0.26 (0.10-0.67) 0.005 
ACE=angiotension converting enzyme; STEMI=ST-segment elevation myocardial infarction; NSTE-ACS= Non ST-segment acute coronary syndrome; 
PCI=percutaneous coronary intervention 
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3.6 MORTALITY IN THE YOUNG POPULATION  
Of the 14,931 patients, 966 (6.5%) died at 30-day follow-up. Outcomes were better in 
young than in older patients. Thirty-day unadjusted survival rates were 98.7% versus 
93.1% for young and older patients, respectively. Length of hospital stay was 
significantly shorter in the young population (6.0 ± 4.6 versus 6.9 ± 6.2 days) (Table 
1).  
Linear regression analysis in the younger (Table 5) revealed that the only variable 
associated with 30-day mortality was female sex: younger women had worse 
outcomes than men of a similar age (OR 6.84, 95% CI 2.23-20.97), even after 
adjusting for use of guideline-recommended acute medications and reperfusion 
therapy (Figure 2). 
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Table 5. Multivariate analysis of factors associated with 30-day all-cause 
mortality in the young population 
 OR  95%CI  P value 
      
Female  6.84  2.23-20.97  0.001 
Diabetes 0.66  0.11-3.88  0.65 
Hypercholesterolemia 1.58  0.48-5.14  0.45 
Current smoker 0.96  0.49-1.89  0.91 
Hypertension 0.92  0.35-2.34  0.85 
Family history of CAD 1.01  0.77-1.30  0.94 
Body Mass Index 0.90  0.75-1.09  0.30 
Medium-High TIMI Risk Index  1.54  0.26-9.14  0.63 
STEMI 1.70  0.33-8.64  0.52 
Systolic blood pressure at baseline 0.99  0.96-1.02  0.73 
Heart rate at baseline at baseline 1.0002  0.95-1.04  0.99 
Time from symptoms onset ≤ 12 hours 0.64  0.17-2.39  0.51 
Chronic kidney disease 1  -  - 
Clinical history of ischemic heart disease  0.83  0.19-3.55  0.81 
Clinical history of cardiovascular 
disorders 
1.21  0.12-11.34  0.86 
CAD= coronary artery disease; TIMI= Thrombolysis In Myocardial Infarction; STEMI=ST-
segment elevation myocardial infarction; PCI=percutaneous coronary intervention; 
CABG=coronary artery bypass graft. 
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Figure 2. Multivariate models to assess the association of young women 
and outcomes: impact of various medications and procedures on the 
odds of mortality for young women. 
ACE=angiotension converting enzyme 
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CHAPTER 4 
 
DISCUSSION 
 
 
The current study represents a contemporary analysis of young patients with ACS, 
from a large and multinational cohort study of ACS patient enrolled in 41 centres in 
12 countries in Europe.  
Our study indicated that approximately 8% of ACS patients referred to ISACS-TC 
Registry were younger than 45 years old and women represented a minority of this 
younger population. The main risk factor in young patients was smoking, together  
with higher BMI and positive family history of CAD. ACS at a young age was 
characterized by less severe coronary artery disease and worse clinical presentation. 
Younger patients had a better outcome than older patients, but younger age had a 
significant protective effect on mortality only in men and not in women. Indeed, 
younger women had worse outcome than men of a similar age. 
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4.1 IS ACS IN YOUNG PATIENT A REAL ISSUE? 
Between the 70s and the 80s, there was an incidence of myocardial infarction in 
young patients of approximately 2% to 6% [19,43]. In the 90s, this incidence was 
shown to grow up ranging around 4% to 10% of myocardial infarctions [19-21,44]. 
Other studies underlined that the incidence of ACS in young patients may vary 
depending on the cut-off age used in the study and may be as low as 0.4% or as high 
as 19% of the population under scrutiny [14-18, 25]. The present study showed that 
nearly 8% of all patients hospitalized with ACS were aged ≤45 years old. This finding 
is consistent with recent work. [9,17, 45-51]. Indeed in the Global Registry of Acute 
Coronary Events (GRACE) study, the prevalence of young ACS patients was 6.3% 
[48]; in the Thai ACS Registry it was 5.8% [49]; and in the ACS Spain registry it was 
7% [17]. 
The mean age of our young ACS cohort was 40.3 ±6 years, which is consistent with 
earlier studies [14, 48, 52]. Sex distribution also followed a pattern already observed 
in previous studies, with a lower percentage of women in the young-age group [48, 
53, 54]. Women have been described to represent a minority of the young patients 
with MI ranging from 5% to 25 % of the overall population under investigation [19-
21] [9,14,22,23]. In our cohort 16% of the young patients with ACS were women, a 
percentage, which consistent with prior findings.  
 
4.2 RISK FACTORS PROFILE OF YOUNG ACS PATIENTS 
Risk factors play a role in the younger patients who had ACS. In the current study, 
smoking and higher BMI (Table 2) were independent predictors of ACS in the young 
population. Obesity is related to cardiovascular risk factors and is an independent risk 
factor for developing coronary artery disease (CAD) [55]. Obesity may, also, confers 
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excess risk of acute coronary events [56] by producing an inflammatory state, which 
may trigger thrombosis and sympathetic nervous and renin-angiotensin system 
activation [57]. Nonetheless, increased BMI did not correlate with increased mortality 
in the young population. These results are concordant with previous findings where 
obesity independently predicted in-hospital death in the older, but not in the younger, 
patients [58]. The reasons for these findings are still unknown. Obese patients may 
have better tolerance to afterload-reducing medications [59]. However, such 
hypothesis does not seem to be a plausible explanation for our findings, as a greater 
proportion of patients were given renin-angiotensin system inhibitors in the older 
patients. Smokers currently have only a vague understanding of the increased risk of 
an acute coronary event that smoking confers. Our cohort consisted of 61.2% current 
smokers in the young versus 33.7% in the old population. Compared with older 
patients, smokers who were younger than age 45 had a significant increase of the risk 
of ACS (OR 1.10; 95% CI 1.06-1.16). These data are consistent with previous work 
that has shown that among patients presenting with myocardial infarction, from 76% 
to 90% of young patients are smokers compared with 40% of older patients [5, 60], 
and that smokers who were younger than age 50 had the worst discrepancy in risk of 
more than eight times that of former and never smokers (RR 8.47; 95% CI 6.80-
10.54) [61]. The reason why smoking imparts such a high risk of acute STEMI among 
those who are youngest remains unclear, since studies of young smokers have 
confirmed that they have fewer traditional cardiovascular risk factors than older 
people. Independently from the pathways mediating its effect, we may emphasize that 
smoking is the most powerful of all risk factors, exerting its effect much sooner than 
any other. 
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4.3  CONFOUNDERS AND TRADITIONAL RISK FACTORS  
We have not information on the rates of substance abuser (particularly marijuana and 
sympathomimetic amines) [51]. Cocaine use is associated with various cardiac 
complications including ACS. Cocaine effects can present up to 76 hours after its use. 
Most of the patients who use cocaine are also smokers and this makes them more 
vulnerable to develop an ACS. Cocaine use results in ACS by various mechanisms 
including coronary vasospasm and heightened sympathetic activity [62]. Alcohol 
abuse has also been reported to be associated with developing ACS in young people, 
although the mechanism is not entirely clear [63].  
The presence of hyperlipidemia, hypertension and diabetes were more common in 
older age group, which is consistent with previous studies [5,64-65]. Although genetic 
studies were not performed, we found that a family history of CAD was not a 
prominent risk factor for ACS in younger patients, a finding that instead is supported 
by the work of others[1,4-9, 66-68]. Chromosomal abnormities were suggested to 
contribute to the onset of ACS by genomic studies [69]. 
 
4.4 CLINICAL PRESENTATION, MANAGEMENT AND 
CORONARY ANGIOGRAPHIC FEATURES 
The clinical presentation of ACS in young adults differs from their older counterparts 
for many reasons. Firstly, because STEMI is the most common clinical manifestation 
of ACS in the younger cases. In our study population, almost seven of ten younger 
cases were admitted with STEMI as index event. This prevalence is slightly less than 
that reported in the PRIAMHO II study [17], in which almost the 80% of younger 
patients suffered from STEMI. Younger patients had lower TIMI risk index and they 
Acute Coronary Syndromes in the Young— The ISACS-TC Experience 
 
 
 
31 
 
reached the hospital earlier than their older counterpart. Moreover they received a 
more aggressive management [4, 48-50], both medical therapy and coronary 
revascularization, except for ACE-inhibitors, possibly because of the lower 
occurrence of previous cardiovascular disease and the lower TIMI risk index at 
admission. 
Angiographic characterization of our younger cohort confirmed evidences from 
previous studies: ACS at a young age is characterized by a higher incidence of normal 
coronary arteries and single vessel coronary artery disease than do older patients [5, 
65, 60, 70, 71]. In our study ACS at a young age was characterized by less severe 
coronary disease: 7% of younger patients had an insignificant coronary disease and 
one third of them had single vessel disease. Our data are in keeping with the CASS 
trial [5], one of the largest reports of angiographic findings in young patients with 
CHD. Zimmerman et al. have shown that normal coronary arteries and single vessel 
coronary disease were more common in the young patients (respectively 18% versus 
3% and 38% versus 24%) and that three-vessel disease was less common (14% versus 
39%) in the younger patients. Difference in proportion might be due to different 
inclusion criteria. In young ACS patients, the predilection for involvement of the left 
anterior descending artery followed by the right coronary and left circumflex arteries 
has been confirmed in the present study [65,71]. Other studies instead did not report 
such finding [5,17]. 
 
4.5 30-DAY MORTALITY: THE ROLE OF AGE AND SEX 
We found a strikingly low hospital mortality: only 16 young patients died during the 
30-day follow-up and they also had a shorter length of hospital stay than the older 
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group [9,23,72]. Although STEMI is the most common clinical manifestation of ACS 
in younger, they had a low TIMI risk index, a less severe coronary disease and they 
more frequently received timely and more aggressively in-hospital medical and 
reperfusion therapy [9, 17, 23, 46- 50, 68, 73, 74]. The different twist of our study is 
that the protective effect on mortally associated with lower age, applies only to young 
men, but not to young women. In the present study, indeed, female sex represented 
the only independent factor associated with mortality. Vaccarino et al. showed that 
young or middle-age women aged <55 years presenting with myocardial infarction 
had a worse long term prognosis than men of the same age [75]. Additionally, the 
mortality of women decreased with increasing age [76]. However, no studies have 
been addressed to investigate whether sex differences in mortality persist in the “true 
young age” i.e. in those patients aged 45 years old or less. In the present study, there 
were 16 patients aged 45 years or less (7 men and 9 women) who had evidence of 
ACS and died. Among these patients, we found at least 50% narrowing of a major 
coronary arterial branch in 11 (7 men and 4 women). Under these circumstances, 
some other contributing cause for a disparity between myocardial oxygen supply and 
demand in women is present. Severe aortic stenosis, systemic arterial hypotension due 
to a variety of causes, stress-induced heart disease and coronary dissection have been 
recognized as selected conditions that may cause ischemia in the absence of 
demonstrable significant coronary artery [77,78]. None of our patients had any of 
these conditions. Nonobstructive CAD is highly prevalent in women and implies 
different sex specific mechanisms that may lead to ACS. Activation of the coagulation 
system and myocardial and vascular function and growth occurs in a sex specific 
manner [79]. Oral contraceptives have been implicated in thromboembolic disease 
[80]. Likewise, functional disorders of the coronary arteries, such as spasms of 
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epicardial arteries or disease of small coronary arteries may arise as a consequence of 
a disturbed interaction between estrogen and vasoprotective nitric oxide system, 
which is probably more pronounced in women than in men [81]. The presence of 
coronary endothelial coronary dysfunction predicts adverse outcome [82]. However, 
we have not available data on endothelial dysfunction in our cohort, and specific 
mechanisms responsible for increased mortality after ACS in women remain 
understood.  
 
4.6 CLINICAL IMPLICATIONS 
ACS at a young age exits and it is characterized by several different aspects than those 
we already know about ACS in middle-aged and elderly patients. First, because 
younger patients have a different risk factors profile. Importantly, rates of ACS were 
compared for age and current smokers were more likely to have an ACS in the young 
group, confirming suggestions from other studies that giving up smoking reduces the 
incidence of acute coronary events in such population. Second, because the most 
common manifestation of ACS in the young is STEMI as index even, which implies 
several years of potential life lost, and long-term disability [1,6,10-12]. 
 
4.6 LIMITATIONS  
There are some limitations that must be noted. The current analysis is an 
observational study, therefore we cannot excluded possible confounding variables not 
controlled. ACS diagnosis in young patients could be a problem because myocarditis 
can mimic an acute MI, therefore the prevalence of ACS at a young age might be 
influenced by an over or mis-diagnosis. We have no data about the use of substance in 
our patients, particularly marijuana and sympathomimetic amines, which have been 
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found correlated to ACS at a younger age [51]. Further, the lack of universal 
definition of "young" patients, made hard the comparison among the few studies 
about this topic. Finally, we have not analyzed long-term follow-up. 
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CHAPTER 5 
 
CONCLUSIONS 
 
 
Our cohort consisted of nearly 1,200 patients younger than 45 years enrolled in the 
ISACS-TC Registry. ACS at a young age is characterized by different risk factors 
profile, less severe coronary disease, worse clinical presentation and higher mortality 
in women. In the present era of preventive cardiology, there are still a number of 
concerns regarding factors underlying ACS in young patients and their mortality rates 
that warrant further investigation, despite the fact that ACS in young patients are 
associated with low incidence and mortality risk. Future analysis will find different 
disease process underlying atherosclerosis manifesting in young patients. However, 
nowadays, both patients and physicians should collaborate to improve and to follow 
public health programmes and anti-smoking campaigns in order to have better 
prognosis and decrease overall morbidity and mortality from CHD.  
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ACS at a young age remains a challenge for clinicians, particular attention should be 
deserved to this age-subgroup, especially if they have a positive family history of 
CAD, if they are smokers or have high BMI, and, mainly, if they are young women. 
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